A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation.
Mutations in two loci encoding cell-cycle-regulatory proteins have been shown to cause familial malignant melanoma. About 20% of melanoma-prone families bear a mutation in the CDKN2A locus, which encodes two unrelated proteins, p16INK4A and p14ARF. Mutations in the other locus, CDK4, are much rarer and have been linked to the disease in only three families worldwide. In the 1960s, a large Norwegian pedigree with multiple atypical nevi and malignant melanomas was identified. Subsequently, six generations and more than 100 family members were traced and 20 cases of melanoma verified. In this article, we report that CDK4 codon 24 is mutated from CGT to CAT (Arg24His) in this unusually large melanoma kindred. Intriguingly, one of the family members had ocular melanoma, but the CDK4 mutation could not be detected in archival tissue samples from this subject. Thus, the case of ocular melanoma in this family was sporadic, suggesting an etiology different from that of the skin tumors. The CDK4 mutation in the Norwegian family was identical to that in melanoma families in France, Australia, and England. Haplotype analysis using microsatellite markers flanking the CDK4 gene and single-nucleotide polymorphisms within the gene did not support the possibility that there was a common founder, but rather indicated at least two independent mutational events. All CDK4 melanoma families known to date have a substitution of amino acid 24. In addition to resulting from selection pressure, this observation may be explained by the CG dinucleotide of codon 24 representing a mutational hot spot in the CDK4 gene.
Molven
Anders
A
Section for Pathology, The Gade Institute, University of Bergen, Haukeland University Hospital, Bergen, Norway. anders.molven@gades.uib.no
Grimstvedt
Magne B
MB
Steine
Solrun J
SJ
Harland
Mark
M
Avril
Marie-Françoise
MF
Hayward
Nicholas K
NK
Akslen
Lars A
LA
D019943:Amino Acid Substitution; D001315:Australia; D002874:Chromosome Mapping; D051358:Cyclin-Dependent Kinase 4; D018844:Cyclin-Dependent Kinases / Q000235:genetics*; D004247:DNA / Q000097:blood / Q000235:genetics / Q000302:isolation & purification; D004416:Dysplastic Nevus Syndrome / Q000235:genetics*; D004739:England; D005134:Eye Neoplasms / Q000235:genetics; D005190:Family; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000235:genetics*; D020125:Mutation, Missense; D009664:Norway; D010375:Pedigree; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D012878:Skin Neoplasms / Q000235:genetics*
D011518:Proto-Oncogene Proteins; D004247:DNA; C495900:CDK4 protein, human; D051358:Cyclin-Dependent Kinase 4; D018844:Cyclin-Dependent Kinases